Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,447 | 926 | 99.3% |
| Education | $109.17 | 8 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Forte Bio-Pharma LLC | $3,544 | 31 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $2,237 | 244 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $962.32 | 60 | $0 (2024) |
| Daiichi Sankyo Inc. | $779.05 | 93 | $0 (2019) |
| SCILEX PHARMACEUTICALS INC. | $752.60 | 46 | $0 (2024) |
| ABBVIE INC. | $574.24 | 49 | $0 (2024) |
| Pernix Therapeutics Holdings, Inc. | $416.34 | 40 | $0 (2019) |
| RedHill Biopharma Inc. | $387.63 | 24 | $0 (2022) |
| Sentynl Therapeutics, Inc. | $324.49 | 22 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $312.13 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,138 | 62 | Valinor Pharma, LLC ($214.99) |
| 2023 | $1,682 | 103 | Forte Bio-Pharma LLC ($352.73) |
| 2022 | $1,423 | 82 | FORTE BIO-PHARMA LLC ($295.07) |
| 2021 | $2,020 | 143 | Forte Bio-Pharma LLC ($386.53) |
| 2020 | $1,306 | 92 | Collegium Pharmaceutical, Inc. ($387.35) |
| 2019 | $1,688 | 145 | Collegium Pharmaceutical, Inc. ($407.22) |
| 2018 | $3,660 | 147 | Forte Bio-Pharma LLC ($2,029) |
| 2017 | $1,639 | 160 | Sentynl Therapeutics, Inc. ($229.33) |
All Payment Transactions
934 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Opioid Analgesic | ||||||
| 11/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Opioid Use Disorder | ||||||
| 10/25/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.35 | General |
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Insomnia | ||||||
| 10/16/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Opioid Analgesic | ||||||
| 10/02/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: OUD | ||||||
| 09/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.37 | General |
| Category: Opioid Analgesic | ||||||
| 09/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Opioid Use Disorder | ||||||
| 09/17/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Analgesic | ||||||
| 09/04/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: PAIN | ||||||
| 08/14/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: PAIN | ||||||
| 08/07/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Opioid Use Disorder | ||||||
| 08/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.69 | General |
| Category: Opioid Analgesic | ||||||
| 07/23/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $3.46 | General |
| Category: Opioid Analgesic | ||||||
| 07/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Analgesic | ||||||
| 07/11/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: Opioid Analgesic | ||||||
| 06/27/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,337 | 3,994 | $378,255 | $229,674 |
| 2022 | 7 | 1,646 | 5,101 | $485,959 | $299,739 |
| 2021 | 10 | 2,176 | 6,908 | $665,089 | $425,397 |
| 2020 | 12 | 2,615 | 7,445 | $687,178 | $374,823 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 456 | 1,805 | $162,450 | $105,558 | 65.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 454 | 1,405 | $126,450 | $84,776 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 347 | 593 | $77,090 | $33,707 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $8,200 | $4,533 | 55.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 25 | $3,495 | $884.58 | 25.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 17 | $278.12 | $142.96 | 51.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 108 | $291.60 | $71.46 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 559 | 2,250 | $202,500 | $119,811 | 59.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 568 | 1,686 | $151,740 | $102,528 | 67.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 408 | 890 | $115,700 | $70,279 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $10,400 | $5,490 | 52.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 35 | $4,893 | $1,374 | 28.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 26 | 172 | $464.40 | $129.57 | 27.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 11 | 16 | $261.76 | $127.34 | 48.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 720 | 3,089 | $278,010 | $174,986 | 62.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 721 | 2,315 | $208,350 | $142,591 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 496 | 1,057 | $137,410 | $89,721 | 65.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 94 | 94 | $18,800 | $9,900 | 52.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 35 | 57 | $7,829 | $2,546 | 32.5% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 13 | 14 | $5,852 | $2,422 | 41.4% |
| 27096 | Injection procedure into sacroiliac joint for anesthetic or steroid | Office | 2021 | 14 | 17 | $5,743 | $1,990 | 34.6% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 12 | 14 | $1,789 | $680.70 | 38.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 33 | 46 | $752.56 | $374.80 | 49.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 38 | 205 | $553.50 | $187.27 | 33.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 873 | 4,008 | $360,720 | $180,397 | 50.0% |
About Dr. Billy Smith, MD
Dr. Billy Smith, MD is a Physical Medicine & Rehabilitation healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346275260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Billy Smith, MD has received a total of $14,556 in payments from pharmaceutical and medical device companies, with $1,138 received in 2024. These payments were reported across 934 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($14,447).
As a Medicare-enrolled provider, Smith has provided services to 7,774 Medicare beneficiaries, totaling 23,448 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Greenville, NC
- Active Since 07/11/2006
- Last Updated 11/28/2018
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1346275260
Products in Payments
- Nalocet (Drug) $2,310
- XTAMPZA (Drug) $1,967
- NALOCET (Drug) $917.93
- RELISTOR (Drug) $839.23
- Morphabond ER (Drug) $656.20
- ZTLido (Drug) $589.15
- Movantik (Drug) $510.48
- MOVANTIK (Drug) $493.88
- UBRELVY (Drug) $441.22
- ZOHYDRO ER (Drug) $346.13
- Levorphanol (Drug) $324.49
- PROLATE (Drug) $315.48
- NURTEC ODT (Drug) $289.99
- SUBLOCADE (Drug) $282.69
- Horizant (Drug) $282.62
- Evzio (Drug) $249.51
- SUBSYS (Drug) $247.27
- RELISTOR ORAL (Drug) $246.20
- QULIPTA (Drug) $203.43
- LEVORPHANOL TARTRATE (Drug) $162.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Greenville
Elizabeth Bagsby, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $33,384
Eleasa Hulon, Md, MD
Physical Medicine & Rehabilitation — Payments: $8,518
Robert Leblond, Md, MD
Physical Medicine & Rehabilitation — Payments: $4,117
Dr. Jennifer Martin, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,390
Dr. Natalia Jolliff, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $3,173
Dr. Patrick Clegg, Do, DO
Physical Medicine & Rehabilitation — Payments: $2,031